Search Results 181-190 of 17137 for egfr

1. A Study Of Depressive Symptoms In ADPKD - Mayo Clinic

   include confirmed clinical diagnosis of ADPKD using Pei-Ravine criteria, age 18-70, Pre-End Stage Kidney Disease, with Stage 1-5 CKD (eGFR >10 ml/min/1.73m² ...

2. Perfusion MRI for Therapy Response Assessment in Brain Cancer - Mayo Clinic

   Evidence of normal kidney function (eGFR of > 60 ml/min/1.72 m^2) as assessed by laboratory testing (or eGFR immediately prior to MRI scan if laboratory ...

3. Enhancing the Natriuretic Peptide System in HFpEF - Mayo Clinic

   * Glomerular filtration rate (eGFR) of \> 50 mL/min/1.73 m\^2 as estimated by the Modification of Diet in Renal Disease equation. In addition to the ...

4. A Study To Assess Adverse Events And Effectiveness Of IntraVenous Infusions Of ABBV-CLS-628 In Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) - Mayo Clinic

   * Estimated glomerular filtration rate (eGFR) \>= 30 mL/min/1.73 m\^2 and \< 90 mL/min/1.73 m\^2, using the Chronic Kidney Disease Epidemiology ...

5. Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia - Mayo Clinic

   ... eGFR >15 mL/min/1.73m2; In patients with enteric hyperoxaluria, eGFR < 45mL/min/1.73m2 at Screening; In patients with enteric hyperoxaluria, plasma oxalate > ...

6. Analysis of the Proteome of PKD-ELVs in Polycystic Kidney Disease and Controls - Mayo Clinic

   CASES: Unable to provide informed consent, eGFR <60ml/min/1.73², frank hematuria, albuminuria >200mg/24hr, Diabetes Mellitus, smoking and positive Gram stain.

7. Evaluation of 18F-Sodium Fluoride Positron Emission Tomography and Diffusion Magnetic Resonance Imaging to Assess Baseline Differences Between Autosomal Dominant Polycystic Kidney Disease and Healthy Subjects, and Disease Progression in Adults with ADPKD - Mayo Clinic

   eGFR ≥ 75 to < 120 mL/min/1.73 m^2 based on the Modified Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation without the race adjustment.

8. Polycystic Kidney Disease Clinical Trials - Mayo Clinic Research

   ... (eGFR > 60 mL/min/m2, BP<130 0="" mmhg),="" and="" these="" correlate="" with ... (eGFR) decline in patients at risk of rapidly progressive Autosomal ...

9. Safety, Tolerability And Pharmacokinetics Of AZD1613 In Adults With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   Participation eligibility · Patients with ADPKD Mayo Class (IB-IE), as per clinical diagnosis (MIC) assessed centrally. · eGFR = 45 to 90 mL/min /1.73m2 · Body ...

10. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    ... (EGFR), defined as follows: EGFR mutation testing of tumor has been performed and did not demonstrate an EGFR tyrosine kinase inhibitor sensitizing mutation ...